Mucormycosis and hemopoietic transplants

Mucormycosis is becoming recognized as a serious complication in patients undergoing hemopoietic transplantation (HT), because it is a major cause of morbidity and mortality. In our institution 4 cases of mucormycosis in post-HT period among 345 patients undergoing HT were diagnosed between 1984 and...

Full description

Saved in:
Bibliographic Details
Published inHaematologica (Roma) Vol. 83; no. 10; pp. 950 - 951
Main Authors Penalver, FJ, Romero, R, Fores, R, Cabrera, R, Briz, M, Fernandez, M
Format Journal Article
LanguageEnglish
Published Italy 01.10.1998
Subjects
Adult
Female
Hematologic Diseases - therapy
Hematopoietic Stem Cell Transplantation - adverse effects
Humans
Immunosuppression
Male
Mucorales - isolation & purification
Mucormycosis - etiology
Mucormycosis - physiopathology
Online AccessGet full text

Cover

More Information
Summary:Mucormycosis is becoming recognized as a serious complication in patients undergoing hemopoietic transplantation (HT), because it is a major cause of morbidity and mortality. In our institution 4 cases of mucormycosis in post-HT period among 345 patients undergoing HT were diagnosed between 1984 and 1997. We studies the clinical characteristics of these cases and we conclude that mucormycosis is not a common infection in patients undergoing HT but that it is followed by a high morbidity and mortality. Maintained neutropenia is the most important risk factor.
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ISSN:0390-6078
1592-8721